Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1996
12/19/1996CA2223978A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders
12/19/1996CA2223962A1 2-substituted benzimidazole derivatives
12/19/1996CA2223939A1 2-substituted benzimidazole derivatives
12/19/1996CA2223891A1 Treatment of insulin resistance
12/19/1996CA2223889A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996CA2223832A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996CA2223718A1 Retinoids and methods of use of same
12/19/1996CA2223717A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996CA2223590A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996CA2223581A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis
12/19/1996CA2223557A1 Method of improving animal health
12/19/1996CA2223533A1 Imidazole compounds
12/19/1996CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996CA2223462A1 Use of pseudopterosins for promoting wound healing
12/19/1996CA2223446A1 Thrombopoietin compositions
12/19/1996CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons)
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223175A1 Methods of inducing bef-1 transcription factor
12/19/1996CA2223092A1 Methods of modulating nf-kb transcription factor
12/19/1996CA2223077A1 Thrombin receptor homolog
12/19/1996CA2223046A1 Methods for increasing hematopoietic cells
12/19/1996CA2222972A1 Reversible cysteine protease inhibitors
12/19/1996CA2222930A1 Treatment of a trabecular meshwork whose cells are subject to inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996CA2222929A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996CA2222789A1 Bone stimulating factor
12/19/1996CA2222739A1 Modulation of calcium channels
12/19/1996CA2222545A1 Quinazolines and pharmaceutical compositions
12/19/1996CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna
12/19/1996CA2222316A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
12/19/1996CA2221646A1 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996CA2221602A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996CA2221601A1 Regulation of cytokine synthesis and release
12/19/1996CA2221146A1 Structurally determined metallo-constructs and applications
12/19/1996CA2220642A1 C-4' modified adenosine kinase inhibitors
12/19/1996CA2220076A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996CA2220006A1 Heterocyclic substituted cyclopentane compounds
12/19/1996CA2219981A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996CA2219755A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996CA2196873A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/19/1996CA2196691A1 Macrophage derived chemokine and chemokine analogs
12/19/1996CA2196334A1 Urokinase receptor ligands
12/18/1996EP0748807A1 Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use
12/18/1996EP0748800A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists
12/18/1996EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them
12/18/1996EP0748793A1 Ketopanthenol with acetylating properties
12/18/1996EP0748627A2 Melatonin agonists for use in the treatment of benign prostatic hyperplasia
12/18/1996EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
12/18/1996EP0748317A1 Novel thiazolidin-4-one derivatives
12/18/1996EP0748313A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
12/18/1996EP0748312A1 Bicyclic carbamates as leukotriene d4 antagonists
12/18/1996EP0748221A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
12/18/1996EP0690855B1 Benzopyranes as potassium channel openers
12/18/1996EP0655059B1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
12/18/1996EP0618802A4 Synthetic compounds and compositions with enhanced cell binding.
12/18/1996EP0555479B1 Epoxysuccinamic acid derivative
12/18/1996EP0526608B1 Therapeutic agents for the treatment of multidrug resistance to cancers
12/18/1996EP0526598B1 New pharmacologically active catechol derivatives
12/18/1996CN1138350A CNTF Family antagonists
12/18/1996CN1138335A Compounds with growth hormone releasing properties
12/18/1996CN1138334A Compounds with growth hormone releasing properties
12/18/1996CN1138332A Pyridazino quinoline compounds
12/18/1996CN1138037A Adhesion receptor antagonists
12/18/1996CN1138029A Fluorophenyl sbstd. alkenylc arboxylic acid-guanidine its preparation method, applied as medicine and diagnosis agent and medicine containing the compound
12/18/1996CN1137914A Aconite granular preparation and its preparation method
12/18/1996CN1137894A Venlafaxine in treatment of hypothalamic amenorrhea in non-depressed women
12/18/1996CN1033585C Preparation of 1,2,4-triazolo(1,5-a) pyrimidine derivatives
12/18/1996CN1033584C Benzo-fused lactams that promote release of growth hormone
12/17/1996US5585497 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin
12/17/1996US5585492 LTA4 Hydrolase inhibitors
12/17/1996US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors
12/17/1996US5585404 3,5,3'-triiodothyronine receptor ligands
12/17/1996US5585388 Substituted pyridines useful as modulators of acetylcholine receptors
12/17/1996US5585386 Mixtures for application to skin or scalp
12/17/1996US5585378 Can be administered for the prevention and treatment of cognitive dysfunctions
12/17/1996US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
12/17/1996US5585374 Anxiolytic agents, antidepressants, cognition activators
12/17/1996US5585359 Inhibitors of farnesyl-protein transferase
12/17/1996US5585358 Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
12/17/1996US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors
12/17/1996US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy
12/17/1996US5585355 Drug delivery with a bradykinin derivatives
12/17/1996US5585233 Mutant; gebnetic engineering
12/14/1996CA2178849A1 N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics
12/12/1996WO1996039524A1 Methods for enhancement of protective immune responses
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039420A1 Human criptin growth factor
12/12/1996WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/12/1996WO1996039410A1 Disodium alendronate formulations
12/12/1996WO1996039408A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
12/12/1996WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists
12/12/1996WO1996039396A1 Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
1 ... 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 ... 1564